SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs earnings beat and stronger outlook, driven by surging AI data-center demand, have fueled a sharp rally and renewed optimism that AI spending is translating into revenue. Traders are also debating whether the gains can hold, citing valuation, weaker cash flow and gaming results, and the risk of AMD becoming more dependent on data-center growth.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros quarterly results topped expectations and its revenue outlook was raised on strong AI-server demand, driving bullish calls that the stock is undervalued and could benefit from short covering. The reaction has been more muted and volatile than many bulls expected, with traders citing margin pressure, negative operating cash flow, inventory growth, and lingering doubts about management and accounting practices.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Aristas quarterly results topped expectations and its forward outlook was stronger than anticipated, with traders pointing to demand for AI data-center networking. The reaction is broadly bullish, though some debate the stocks elevated valuation and warn of profit-taking or further volatility.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

AMDs strong earnings and upbeat outlook have renewed optimism that AI-chip demand remains robust, with traders debating whether the results will lift Nvidia or sharpen competition; others remain cautious about AI spending, valuations, and Nvidias difficulty sustaining its rebound.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

A letter from 28 HOPE-3 investigators urging FDA approval of deramiocel has renewed optimism ahead of the November 22 decision for Capricors Duchenne muscular dystrophy therapy. Traders are also debating the FDAs prior concerns about the trial data and speculating that short covering is amplifying the move; approval remains uncertain.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas is drawing attention after a Q3 earnings beat and stronger Q4 guidance, with its AI infrastructure growth and Nvidia-related 800V power work adding to the bullish case. Traders remain divided: bulls see traction in the AI data-center pivot, while skeptics question whether the partnerships will translate into sizable customer orders and note ongoing losses.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs strong quarterly results and upbeat outlook are the focus, but the stocks drop despite the beat has prompted debate over its premium valuation and exposure to hyperscaler AI spending. Some traders see the selloff as a buying opportunity, while others argue that high growth may already be priced in.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

U.S. midterm election outcomes dominate discussion, with traders debating whether Democratic gains would weaken Trumps political position and pressure DJT or whether Republican results could support a rally. The stocks political ties are central to the debate, while reactions range from bullish election-driven bounce expectations to bearish selloff calls.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters quarterly results are drawing attention, with traders focusing on revenue growth, better-than-expected results and higher fourth-quarter revenue guidance. Many view the report as evidence of improving momentum, while others remain cautious about ongoing losses and volatile price action.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevras Q3 results, which traders describe as a solid quarter with an EPS beat and continued MIPLYFFA growth, are the main catalyst; the company also discussed a planned filing to expand treatment to infants. Bulls point to the business and cash position as evidence of undervaluation, while others are frustrated by the muted share reaction and remain focused on uncertainty around the EMA review.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Barings Corporate Investors Announces Quarterly Cash Dividend Of $0.40 Per Share

The Board of Trustees of Barings Corporate Investors (NYSE: MCI) (the "Trust") today announced that it has declared a quarterly dividend of $0.40 per share payable on November 13, 2026, to shareholders of record on November 2, 2026. The Trust will report preliminary financial results for the third...

Barings Corporate Investors Reports Preliminary Second Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.40 Per Share

The Board of Trustees of Barings Corporate Investors (NYSE: MCI) (the "Trust") met on August 13, 2026, and would like to report its preliminary financial results for the second quarter of 2026. Financial Highlights(1) Three Months Ended June 30, 2026 Three Months Ended March 31, 2026 Total Amount...

Barings Corporate Investors Reports Preliminary First Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.40 Per Share

The Board of Trustees of Barings Corporate Investors (NYSE: MCI) (the "Trust") met on May 14, 2026, and would like to report its preliminary financial results for the first quarter of 2026. Financial Highlights(1) Three Months Ended March 31, 2026 Three Months Ended December 31, 2025 Total Amount...

Barings Corporate Investors (NYSE:MCI) Short Interest Update

Barings Corporate Investors (NYSE:MCI - Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totaling 3,422...

Barings Corporate Investors (NYSE:MCI) Stock Price Passes Below Two Hundred Day Moving Average   - Here's What Happened

Barings Corporate Investors (NYSE:MCI) Share Price Crosses Below 200-Day Moving Average - Here's Why...

Barings Corporate Investors (NYSE:MCI) Shares Pass Below 200-Day Moving Average - Here's Why

Barings Corporate Investors (NYSE:MCI) Stock Price Passes Below 200-Day Moving Average - Here's What Happened...

Barings Corporate Investors (NYSE:MCI - Get Free Report) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 61,574 shares...

Barings Corporate Investors Reports Preliminary Fourth Quarter 2025 Results

The Board of Trustees of Barings Corporate Investors (NYSE: MCI) (the 'Trust') met on February 26, 2026, and would like to report its preliminary financial results for the fourth quarter of 2025...

Barings Corporate Investors (NYSE:MCI - Get Free Report) was the target of a significant growth in short interest in January. As of January 30th, there was short interest totaling 31,286 shares, a...

Barings Corporate Investors (NYSE:MCI) Sees Significant Drop in Short Interest

Barings Corporate Investors (NYSE:MCI - Get Free Report) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totaling...

Current Price	$17.16
Prev Close	$17.29
Open	$17.42
Dividend Yield	N/A
50-Day Moving Average	$18.40
Beta	0.21
Avg. Volume	29,832.75
PE Ratio	N/A

52-Week High	$21.50
52-Week Low	$16.21
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

MCI Fundamentals